Similar Articles
1101 Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival
1102 Surgical approach for hepatitis C virus-related hepatocellular carcinoma
1103 Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
1104 FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
1105 Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis
1106 Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma
1107 Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out
1108 Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma
1109 Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques
1110 Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA